Abstract:Depression, which is a disease of heterogeneous etiology, is characterized by high disability and mortality rates. Gut microbiota are associated with the development of depression. To further explore any differences in the mechanisms of depression induced by gut microbiota and traditional stresses, as well as facilitate the development of microbiota-based interventions, a fecal microbiota transplantation (FMT) depression model was made. This was achieved by transplanting feces from major depressive disorder (MDD) patients into germ-free mice. Second, the mechanisms of the depression induced by gut microbiota were analyzed in comparison with those of the depression caused by different forms of stress It turned out that mice exhibited depressive-like behavior after FMT. Then, PCR array analysis was performed on the hippocampus of the depressed mice to identify differentially expressed genes (DEGs). The KEGG analysis revealed that the pathways of depression induced by gut microbes are closely associated with immuno-inflammation. To determine the pathogenic pathways of physiological stress and psychological stress-induced depression, raw data was extracted from several databases and KEGG analysis was performed. The results from the analysis revealed that the mechanisms of depression induced by physiological and psychological stress are closely related to the regulation of neurotransmitters and energy metabolism. Interestingly, the immunoinflammatory response was distinct across different etiologies that induced depression. The findings showed that gut microbiota dysbiosis-induced depression was mainly associated with adaptive immunity, while physiological stress-induced depression was more linked to innate immunity. This study compared the pathogenesis of depression caused by gut microbiota dysbiosis, and physiological and psychological stress. We explored new intervention methods for depression and laid the foundation for precise treatment.

Impact of the Gut Microbiota-Th17 Cell Axis on Inflammatory Depression

Immunoregulatory role of the gut microbiota in inflammatory depression

Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Altered gut bacterial-fungal interkingdom networks in children and adolescents with depression

Mood and Microbes: a Comprehensive Review of Intestinal Microbiota’s Impact on Depression

Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression

Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder

Depressed gut? The microbiota-diet-inflammation trialogue in depression

Potential role of gut microbiota in major depressive disorder: A review

The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

Gut microbiota and its metabolites in depression: from pathogenesis to treatment

Depression-associated gut microbes, metabolites and clinical trials

Gut-brain axis in depression: Crosstalk between neuroinflammation and gut microbiota

Probiotics for the treatment of depression and its comorbidities: A systemic review

Core Antibiotic Resistance Genes Mediate Gut Microbiota to Intervene in the Treatment of Major Depressive Disorder

Review of research progress on intestinal microbiota based on metabolism and inflammation for depression

Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells

The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story

Gut microbiota–brain axis in depression: The role of neuroinflammation

A comprehensive analysis of the differential expression in the hippocampus of depression induced by gut microbiota compared to traditional stress